z-logo
open-access-imgOpen Access
BRAF ‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis
Author(s) -
Abbati Francesca,
Altimari Annalisa,
Corti Barbara,
Dika Emi,
Sperandi Francesca,
Melotti Barbara
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3982
Subject(s) - medicine , dabrafenib , trametinib , melanoma , nodal , metastasis , metastatic melanoma , mek inhibitor , cancer research , targeted therapy , oncology , vemurafenib , cancer , mapk/erk pathway , kinase , biology , microbiology and biotechnology
We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a BRAF/MEK inhibitor combination therapy (dabrafenib/trametinib), which was demonstrated to be effective and well‐tolerated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here